TransPerfect's device-independent call center solutions allow you to easily and affordably route calls to our global call centers where we intake and process cases, either as part of a clinical trial or in supporting post-marketing pharmacovigilance efforts (adverse events, medical information, product complaints, patient registries, etc.).
As life sciences companies move to semi-virtual environments keeping only the most vital functions in house, more and more Trial Master Files are being converted to an eTMF format.
You want a clinical trial management system (CTMS) that is simple enough for all stakeholders to use and that delivers results.
Merge CTMS for Investigators offers groundbreaking ease-of-use, power, and flexibility, helping you organize and centralize your clinical research. Scalable, secure, and backed by the most comprehensive customer support program in the industry, Merge CTMS is the site success solution.
You are constantly facing increased competition for the best studies, mountains of papers and spreadsheets, vast array of complex sponsor contracts to track, and pressure to watch the bottom line.
Through enhanced productivity and business management tools, Merge CTMS for Investigators allows research organizations to centralize study information, organize research activities, and improve recruitment and financial performance.
Merge eClinical OS™, our flagship product, is a truly unified platform designed to help clients manage and run studies faster and more cost effectively.
Increased pressure from regulatory authorities to conduct endpoint adjudication, as well as business pressures to reduce the overall cost of trials, leaves many companies searching for ways to streamline the adjudication processes and shorten clinical trial timelines.
Merge’s web-based trial management tools centralize your operation’s essential study details and provide easier access anytime, anywhere.
Merge’s web-based trial management tools centralize your operation’s essential study details and provide easier access anytime, anywhere.
|
|
|
|
|
|
|
|
|